{"brief_title": "A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)", "brief_summary": "The purpose of this study and 12 month extension is to evaluate the effects of two investigational drugs on osteoporosis in postmenopausal women.", "condition": ["Osteoporosis, Postmenopausal"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0217, alendronate sodium/Duration of Intervention: 12 mo", "Comparator: risedronate / Duration of Intervention: 12 mo"], "criteria": "Inclusion Criteria: - Postmenopausal women with osteoporosis Exclusion Criteria: - Any known allergy to the study drug", "gender": "Female", "minimum_age": "40 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Osteoporosis", "Osteoporosis, Postmenopausal", "Alendronate", "Risedronate Sodium"], "id": "NCT00092040"}